
LINK . SPRINGER . COM {
}
Title:
Phase I trial of combined treatment with ch14.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma | Cancer Immunology, Immunotherapy
Description:
Purpose: We conducted a phase I trial of interleukin 2 (IL-2) in combination with chimeric 14.18 (ch14.18) and murine R24 antibodies to determine the maximal tolerated dose (MTD), immunological effects, and toxicity of this treatment combination. Experimental Design: Twenty-seven patients with either melanoma (23 patients) or sarcoma (4 patients) were enrolled to receive a combination therapy with ch14.18 and R24 antibodies together with continuous infusion of Roche IL-2 (1.5×106 U/m2/day, 26 patients) or Chiron IL-2 (4.5×106 U/m2/day, 1 patient) given 4 days/week for 3 weeks. The antibodies ch14.18 (2–7.5 mg/m2/day) and R24 (1–10 mg/m2/day) were scheduled to be administered for 5 days during the second week of IL-2 therapy. Results: When given in combination in this study, the MTD for ch14.18 was 5 mg/m2/day and the MTD for R24 was 5 mg/m2/day. Dose-limiting toxicities were severe allergic reactions to both ch14.18 and R24 as well as pain related to ch14.18. This ch14.18 MTD was lower than the 7.5 mg/m2/day MTD previously determined for ch14.18 given alone with the same dose and schedule of IL-2. Immunological effects included the induction of lymphokine-activated killer (LAK) activity and antibody-dependent cell-mediated cytoxicity (ADCC). Anti-idiotype response to ch14.18 was seen in six patients, including two melanoma patients who had a partial response to treatment. In addition to two partial responses, four patients had a stable disease and one patient remained without any evidence of disease. Conclusions: Immunotherapy with IL-2 in combination with ch14.18 and R24 antibodies augments LAK function and ADCC measured in vitro in all patients. While there exist theoretical advantages of combining these two antibodies, the MTD of ch14.18 and of R24 were lower than the MTD of each antibody in prior studies evaluating single antibody therapy with IL-2. As such, the combination of these two antibodies together with IL-2 therapy appeared to influence the MTD and toxicity of each of the administered antibodies.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {📚}
- Science
- Health & Fitness
- Education
Content Management System {📝}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of link.springer.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 7,643,328 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {💸}
We find it hard to spot revenue streams.
Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Link.springer.com has a revenue plan, but it's either invisible or we haven't found it.
Keywords {🔍}
google, scholar, cas, article, pubmed, cancer, patients, melanoma, sondel, antibody, interleukin, hank, phase, albertini, therapy, trial, monoclonal, gan, immunotherapy, antibodies, university, reisfeld, res, wisconsin, usa, treatment, mtd, tumor, clin, cell, combination, clinical, antigd, department, madison, chimeric, response, surfus, schiller, immunother, rosenberg, immunol, privacy, cookies, content, research, kendra, effects, mgmday, lymphocytes,
Topics {✒️}
antibody-dependent cell-mediated cytoxicity granulocyte-macrophage-colony stimulating factor month download article/chapter anti-gd2 antibody therapy li-yin lee chimeric anti-gd2 antibody antibody-dependent cytotoxicity adoptive-cell-transfer therapy targeted interleukin-2 therapy phase ib/ii trial antibody-cytokine fusion proteins lymphokine-activated killer nih grants m01-rr03186 article cancer immunology human neuroblastoma cells gd3 ganglioside full article pdf subcutaneous tumor mediated mouse monoclonal antibody renal cell cancer chimeric antidisialoganglioside antibody cell growth factor related subjects enhance tumor immunotherapy cultured autologous tumor privacy choices/manage cookies cell-mediated lysis nk cell assays shipe-spotloe jm r24 monoclonal antibody monoclonal antibody r24 il-2 therapy appeared potent antitumor response p30-ca14520 rights anti-idiotype vaccines anti-idiotype response anti-idiotypic response 5 mg/m2/day 1–10 mg/m2/day 18-il-2 fusion protein anti-gd3 phase ib trial maximal tolerated dose dose-limiting toxicities immunological effects included recombinant interleukin-2 preparations european economic area severe allergic reactions exist theoretical advantages invaded lymph node
Schema {🗺️}
WebPage:
mainEntity:
headline:Phase I trial of combined treatment with ch14.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma
description:
Purpose: We conducted a phase I trial of interleukin 2 (IL-2) in combination with chimeric 14.18 (ch14.18) and murine R24 antibodies to determine the maximal tolerated dose (MTD), immunological effects, and toxicity of this treatment combination. Experimental Design: Twenty-seven patients with either melanoma (23 patients) or sarcoma (4 patients) were enrolled to receive a combination therapy with ch14.18 and R24 antibodies together with continuous infusion of Roche IL-2 (1.5×106 U/m2/day, 26 patients) or Chiron IL-2 (4.5×106 U/m2/day, 1 patient) given 4 days/week for 3 weeks. The antibodies ch14.18 (2–7.5 mg/m2/day) and R24 (1–10 mg/m2/day) were scheduled to be administered for 5 days during the second week of IL-2 therapy. Results: When given in combination in this study, the MTD for ch14.18 was 5 mg/m2/day and the MTD for R24 was 5 mg/m2/day. Dose-limiting toxicities were severe allergic reactions to both ch14.18 and R24 as well as pain related to ch14.18. This ch14.18 MTD was lower than the 7.5 mg/m2/day MTD previously determined for ch14.18 given alone with the same dose and schedule of IL-2. Immunological effects included the induction of lymphokine-activated killer (LAK) activity and antibody-dependent cell-mediated cytoxicity (ADCC). Anti-idiotype response to ch14.18 was seen in six patients, including two melanoma patients who had a partial response to treatment. In addition to two partial responses, four patients had a stable disease and one patient remained without any evidence of disease. Conclusions: Immunotherapy with IL-2 in combination with ch14.18 and R24 antibodies augments LAK function and ADCC measured in vitro in all patients. While there exist theoretical advantages of combining these two antibodies, the MTD of ch14.18 and of R24 were lower than the MTD of each antibody in prior studies evaluating single antibody therapy with IL-2. As such, the combination of these two antibodies together with IL-2 therapy appeared to influence the MTD and toxicity of each of the administered antibodies.
datePublished:2005-09-27T00:00:00Z
dateModified:2005-09-27T00:00:00Z
pageStart:761
pageEnd:774
sameAs:https://doi.org/10.1007/s00262-005-0069-7
keywords:
Melanoma
Immunotherapy
Ganglioside GD2
Ganglioside GD3
Antibody-dependent cell cytotoxicity
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-005-0069-7/MediaObjects/262_2005_69_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-005-0069-7/MediaObjects/262_2005_69_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-005-0069-7/MediaObjects/262_2005_69_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-005-0069-7/MediaObjects/262_2005_69_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-005-0069-7/MediaObjects/262_2005_69_Fig5_HTML.gif
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:55
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Brian S. Choi
affiliation:
name:University of Wisconsin
address:
name:Department of Medicine, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Paul M. Sondel
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:University of Wisconsin
address:
name:Department of Pediatrics, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:University of Wisconsin
address:
name:Department of Genetics, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Jacquelyn A. Hank
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Heidi Schalch
affiliation:
name:University of Wisconsin
address:
name:Department of Medicine, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Jacek Gan
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:David M. King
affiliation:
name:University of Wisconsin
address:
name:Department of Medicine, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Kari Kendra
affiliation:
name:Ohio State University
address:
name:Department of Hematology and Oncology, Ohio State University, Columbus, USA
type:PostalAddress
type:Organization
type:Person
name:David Mahvi
affiliation:
name:University of Wisconsin
address:
name:Department of Surgery, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Li-Yin Lee
affiliation:
name:University of Wisconsin
address:
name:Department of Biostatistics, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:KyungMann Kim
affiliation:
name:University of Wisconsin
address:
name:Department of Biostatistics, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Mark R. Albertini
affiliation:
name:University of Wisconsin
address:
name:Department of Medicine, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:University of Wisconsin
address:
name:K4/414 Clinical Science Center, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Phase I trial of combined treatment with ch14.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma
description:
Purpose: We conducted a phase I trial of interleukin 2 (IL-2) in combination with chimeric 14.18 (ch14.18) and murine R24 antibodies to determine the maximal tolerated dose (MTD), immunological effects, and toxicity of this treatment combination. Experimental Design: Twenty-seven patients with either melanoma (23 patients) or sarcoma (4 patients) were enrolled to receive a combination therapy with ch14.18 and R24 antibodies together with continuous infusion of Roche IL-2 (1.5×106 U/m2/day, 26 patients) or Chiron IL-2 (4.5×106 U/m2/day, 1 patient) given 4 days/week for 3 weeks. The antibodies ch14.18 (2–7.5 mg/m2/day) and R24 (1–10 mg/m2/day) were scheduled to be administered for 5 days during the second week of IL-2 therapy. Results: When given in combination in this study, the MTD for ch14.18 was 5 mg/m2/day and the MTD for R24 was 5 mg/m2/day. Dose-limiting toxicities were severe allergic reactions to both ch14.18 and R24 as well as pain related to ch14.18. This ch14.18 MTD was lower than the 7.5 mg/m2/day MTD previously determined for ch14.18 given alone with the same dose and schedule of IL-2. Immunological effects included the induction of lymphokine-activated killer (LAK) activity and antibody-dependent cell-mediated cytoxicity (ADCC). Anti-idiotype response to ch14.18 was seen in six patients, including two melanoma patients who had a partial response to treatment. In addition to two partial responses, four patients had a stable disease and one patient remained without any evidence of disease. Conclusions: Immunotherapy with IL-2 in combination with ch14.18 and R24 antibodies augments LAK function and ADCC measured in vitro in all patients. While there exist theoretical advantages of combining these two antibodies, the MTD of ch14.18 and of R24 were lower than the MTD of each antibody in prior studies evaluating single antibody therapy with IL-2. As such, the combination of these two antibodies together with IL-2 therapy appeared to influence the MTD and toxicity of each of the administered antibodies.
datePublished:2005-09-27T00:00:00Z
dateModified:2005-09-27T00:00:00Z
pageStart:761
pageEnd:774
sameAs:https://doi.org/10.1007/s00262-005-0069-7
keywords:
Melanoma
Immunotherapy
Ganglioside GD2
Ganglioside GD3
Antibody-dependent cell cytotoxicity
Oncology
Immunology
Cancer Research
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-005-0069-7/MediaObjects/262_2005_69_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-005-0069-7/MediaObjects/262_2005_69_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-005-0069-7/MediaObjects/262_2005_69_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-005-0069-7/MediaObjects/262_2005_69_Fig4_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-005-0069-7/MediaObjects/262_2005_69_Fig5_HTML.gif
isPartOf:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:55
type:
Periodical
PublicationVolume
publisher:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Brian S. Choi
affiliation:
name:University of Wisconsin
address:
name:Department of Medicine, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Paul M. Sondel
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:University of Wisconsin
address:
name:Department of Pediatrics, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:University of Wisconsin
address:
name:Department of Genetics, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Jacquelyn A. Hank
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Heidi Schalch
affiliation:
name:University of Wisconsin
address:
name:Department of Medicine, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Jacek Gan
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:David M. King
affiliation:
name:University of Wisconsin
address:
name:Department of Medicine, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Kari Kendra
affiliation:
name:Ohio State University
address:
name:Department of Hematology and Oncology, Ohio State University, Columbus, USA
type:PostalAddress
type:Organization
type:Person
name:David Mahvi
affiliation:
name:University of Wisconsin
address:
name:Department of Surgery, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Li-Yin Lee
affiliation:
name:University of Wisconsin
address:
name:Department of Biostatistics, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:KyungMann Kim
affiliation:
name:University of Wisconsin
address:
name:Department of Biostatistics, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
type:Person
name:Mark R. Albertini
affiliation:
name:University of Wisconsin
address:
name:Department of Medicine, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:University of Wisconsin
address:
name:K4/414 Clinical Science Center, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Cancer Immunology, Immunotherapy
issn:
1432-0851
0340-7004
volumeNumber:55
Organization:
name:Springer-Verlag
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:University of Wisconsin
address:
name:Department of Medicine, University of Wisconsin, Madison, USA
type:PostalAddress
name:University of Wisconsin
address:
name:Department of Human Oncology, University of Wisconsin, Madison, USA
type:PostalAddress
name:University of Wisconsin
address:
name:Department of Pediatrics, University of Wisconsin, Madison, USA
type:PostalAddress
name:University of Wisconsin
address:
name:Department of Genetics, University of Wisconsin, Madison, USA
type:PostalAddress
name:University of Wisconsin
address:
name:Department of Human Oncology, University of Wisconsin, Madison, USA
type:PostalAddress
name:University of Wisconsin
address:
name:Department of Medicine, University of Wisconsin, Madison, USA
type:PostalAddress
name:University of Wisconsin
address:
name:Department of Human Oncology, University of Wisconsin, Madison, USA
type:PostalAddress
name:University of Wisconsin
address:
name:Department of Medicine, University of Wisconsin, Madison, USA
type:PostalAddress
name:Ohio State University
address:
name:Department of Hematology and Oncology, Ohio State University, Columbus, USA
type:PostalAddress
name:University of Wisconsin
address:
name:Department of Surgery, University of Wisconsin, Madison, USA
type:PostalAddress
name:University of Wisconsin
address:
name:Department of Biostatistics, University of Wisconsin, Madison, USA
type:PostalAddress
name:University of Wisconsin
address:
name:Department of Biostatistics, University of Wisconsin, Madison, USA
type:PostalAddress
name:University of Wisconsin
address:
name:Department of Medicine, University of Wisconsin, Madison, USA
type:PostalAddress
name:University of Wisconsin
address:
name:K4/414 Clinical Science Center, University of Wisconsin, Madison, USA
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Brian S. Choi
affiliation:
name:University of Wisconsin
address:
name:Department of Medicine, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:Paul M. Sondel
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:University of Wisconsin
address:
name:Department of Pediatrics, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:University of Wisconsin
address:
name:Department of Genetics, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:Jacquelyn A. Hank
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:Heidi Schalch
affiliation:
name:University of Wisconsin
address:
name:Department of Medicine, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:Jacek Gan
affiliation:
name:University of Wisconsin
address:
name:Department of Human Oncology, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:David M. King
affiliation:
name:University of Wisconsin
address:
name:Department of Medicine, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:Kari Kendra
affiliation:
name:Ohio State University
address:
name:Department of Hematology and Oncology, Ohio State University, Columbus, USA
type:PostalAddress
type:Organization
name:David Mahvi
affiliation:
name:University of Wisconsin
address:
name:Department of Surgery, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:Li-Yin Lee
affiliation:
name:University of Wisconsin
address:
name:Department of Biostatistics, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:KyungMann Kim
affiliation:
name:University of Wisconsin
address:
name:Department of Biostatistics, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:Mark R. Albertini
affiliation:
name:University of Wisconsin
address:
name:Department of Medicine, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
name:University of Wisconsin
address:
name:K4/414 Clinical Science Center, University of Wisconsin, Madison, USA
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Medicine, University of Wisconsin, Madison, USA
name:Department of Human Oncology, University of Wisconsin, Madison, USA
name:Department of Pediatrics, University of Wisconsin, Madison, USA
name:Department of Genetics, University of Wisconsin, Madison, USA
name:Department of Human Oncology, University of Wisconsin, Madison, USA
name:Department of Medicine, University of Wisconsin, Madison, USA
name:Department of Human Oncology, University of Wisconsin, Madison, USA
name:Department of Medicine, University of Wisconsin, Madison, USA
name:Department of Hematology and Oncology, Ohio State University, Columbus, USA
name:Department of Surgery, University of Wisconsin, Madison, USA
name:Department of Biostatistics, University of Wisconsin, Madison, USA
name:Department of Biostatistics, University of Wisconsin, Madison, USA
name:Department of Medicine, University of Wisconsin, Madison, USA
name:K4/414 Clinical Science Center, University of Wisconsin, Madison, USA
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(131)
- What's the income generated by https://www.springernature.com/gp/authors each month?
- What's the profit of https://link.springernature.com/home/?
- What's the financial intake of https://order.springer.com/public/cart?
- How much money does https://submission.nature.com/new-submission/262/3 make?
- How much does https://www.springernature.com/gp/librarians/licensing/agc/journals pull in?
- What's the financial outcome of https://doi.org/10.1097%2F00002371-199607000-00004?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Systemic%20interleukin-2%20modulates%20the%20anti-idiotypic%20response%20to%20chimeric%20anti-GD2%20antibody%20in%20patients%20with%20melanoma&journal=J%20immunother&doi=10.1097%2F00002371-199607000-00004&volume=19&pages=278-295&publication_year=1996&author=Albertini%2CMR&author=Gan%2CJ&author=Jaeger%2CP&author=Hank%2CJA&author=Storer%2CB&author=Schell%2CK&author=Rivest%2CT&author=Surfus%2CJ&author=Reisfeld%2CRA&author=Schiller%2CJH&author=Sondel%2CPM?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9815810 income
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Phase%20IB%20trial%20of%20chimeric%20antidisialoganglioside%20antibody%20plus%20interleukin%202%20for%20melanoma%20patients&journal=Clin%20Cancer%20Res&volume=3&pages=1277-1288&publication_year=1997&author=Albertini%2CMR&author=Hank%2CJA&author=Schiller%2CJH&author=Khorsand%2CM&author=Borchert%2CAA&author=Gan%2CJ&author=Behhofer%2CR&author=Storer%2CB&author=Reisfeld%2CRA&author=Sondel%2CPM produce monthly?
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1599802?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Strategies%20for%20improving%20antitumor%20activity%20utilizing%20IL-2%3A%20preclinical%20models%20and%20analysis%20of%20antitumor%20activity%20of%20lymphocytes%20from%20patients%20receiving%20IL-2&journal=Biotherapy&doi=10.1007%2FBF02174205&volume=4&pages=189-198&publication_year=1992&author=Albertini%2CMR&author=Hank%2CJA&author=Sondel%2CPM
- Income figures for http://scholar.google.com/scholar_lookup?&title=Phase%20IB%20trial%20for%20malignant%20melanoma%20using%20R24%20monoclonal%20antibody%2C%20interleukin-2%2Falpha-interferon&journal=Med%20Onco1&doi=10.1007%2FBF02821938&volume=15&pages=191-198&publication_year=1998&author=Alpaugh%2CRK&author=Mehren%2CM&author=Palazzo%2CI&author=Atkins%2CMB&author=Sparano%2CJA&author=Schuchter%2CL&author=Weiner%2CLM&author=Dutcher%2CJP
- Explore the financials of https://doi.org/10.1016%2Fj.semcancer.2003.09.009
- Find out how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15001164 earns monthly
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Dynamic%20changes%20of%20specific%20T%20cell%20responses%20to%20melanoma%20correlate%20with%20IL-2%20administration&journal=Semin%20Cancer%20Biol&doi=10.1016%2Fj.semcancer.2003.09.009&volume=13&pages=449-459&publication_year=2003&author=Andersen%2CMH&author=Gehl%2CJ&author=Reker%2CS&author=Pedersen%2CLO&author=Becker%2CJC&author=Geertsen%2CP&author=thor%20Straten%2CP
- http://scholar.google.com/scholar_lookup?&title=High-dose%20recombinant%20interleukin%202%20therapy%20for%20patients%20with%20metastatic%20melanoma%3A%20analysis%20of%20270%20patients%20treated%20between%201985%20and%201993&journal=J%20Clin%20Onco1&volume=17&pages=2105-2116&publication_year=1999&author=Atkins%2CMB&author=Lotze%2CMT&author=Dutcher%2CJP&author=Fisher%2CRI&author=Weiss%2CG&author=Margolin%2CK&author=Abrams%2CJ&author=Sznol%2CM&author=Parkinson%2CD&author=Hawkins%2CM&author=Paradise%2CC&author=Kunkel%2CL&author=Rosenberg%2CSA's total income per month
- Get to know https://doi.org/10.1097%2F00008390-199212000-00009's earnings
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=1292783?
- How much income does http://scholar.google.com/scholar_lookup?&title=Treatment%20with%20high%20dose%20mouse%20monoclonal%20%28anti-GD3%29%20antibody%20R24%20in%20patients%20with%20metastatic%20melanoma&journal=Melanoma%20Res&doi=10.1097%2F00008390-199212000-00009&volume=2&pages=355-362&publication_year=1992&author=Bajorin%2CDF&author=Chapman%2CPB&author=Wong%2CGY&author=Cody%2CBV&author=Cordon-Cardo%2CC&author=Dantes%2CL&author=Templeton%2CMA&author=Scheinberg%2CD&author=Oettgen%2CHF&author=Houghton%2CAN have?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2253196
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Phase%20I%20evaluation%20of%20a%20combination%20of%20monoclonal%20antibody%20R24%20and%20interleukin-2%20in%20patients%20with%20metastatic%20melanoma&journal=Cancer%20Res&volume=50&pages=7490-7495&publication_year=1990&author=Bajorin%2CDF&author=Chapman%2CPB&author=Wong%2CG&author=Coit%2CDG&author=Kunicka%2CJ&author=Dimaggio%2CJ&author=Cordon-Cardo%2CC&author=Umacher%2CC&author=Dantes%2CL&author=Templeton%2CMA bring in?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Effect%20of%20a%20chimeric%20anti-ganglioside%20GD2%20antibody%20on%20cell-mediated%20lysis%20of%20human%20neuroblastoma%20cells&journal=Cancer%20Res&volume=54&pages=144-149&publication_year=1992&author=Barker%2CE&author=Mueller%2CBM&author=Handgretinger%2CR&author=Herter%2CM&author=Yu%2CAL&author=Reisfeld%2CRA?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11249733 generate?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=The%20anti-idiotype%20vaccines%20for%20immunotherapy&journal=Curr%20Opin%20Mol%20Ther&volume=3&pages=63-69&publication_year=2001&author=Bhattacharya-Chatterjee%2CM&author=Chatterjee%2CSK&author=Foon%2CKA
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10914706
- How much does http://scholar.google.com/scholar_lookup?&title=Induction%20of%20Ab3%20and%20Ab3%E2%80%99%20antibody%20was%20associated%20with%20long-term%20survival%20after%20anti-GD2%20antibody%20therapy%20of%20stage%204%20neuroblastoma&journal=Clin%20Cancer%20Res&volume=6&pages=2653-2660&publication_year=2000&author=Cheung%2CNV&author=Guo%2CH&author=Heller%2CG&author=Cheung%2CIY pull in?
- How much does https://doi.org/10.1038%2Fnrc1167 pull in monthly?
- http://scholar.google.com/scholar_lookup?&title=Adoptive-cell-transfer%20therapy%20for%20the%20treatment%20of%20patients%20with%20cancer&journal=Nature%20Rev%20Cancer&doi=10.1038%2Fnrc1167&volume=3&pages=666-675&publication_year=2003&author=Dudley%2CME&author=Rosenberg%2CSA's total income per month
- What's the monthly money flow for https://doi.org/10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C317%3A%3AAID-CNCR21%3E3.0.CO%3B2-W?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9217046 have monthly?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=A%20phase%20I%2FIB%20trial%20of%20murine%20monoclonal%20anti-GD2%20antibody%2014.G2a%20plus%20interleukin-2%20in%20children%20with%20refractory%20neuroblastoma%3A%20a%20report%20of%20the%20Children%E2%80%99s%20Cancer%20Group&journal=Cancer&doi=10.1002%2F%28SICI%291097-0142%2819970715%2980%3A2%3C317%3A%3AAID-CNCR21%3E3.0.CO%3B2-W&volume=80&pages=317-333&publication_year=1997&author=Frost%2CJD&author=Hank%2CJA&author=Reaman%2CGH&author=Frierdich%2CS&author=Seeger%2CRC&author=Gan%2CJ&author=Anderson%2CPM&author=Ettinger%2CLJ&author=Cairo%2CMS&author=Blazar%2CBR&author=Krailo%2CMD&author=Matthay%2CKK&author=Reisfeld%2CRA&author=Sondel%2CPM?
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10066660
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Specific%20enzyme-linked%20immunosorbent%20assays%20for%20quantitation%20of%20antibody-cytokine%20fusion%20proteins&journal=Clin%20Diagn%20Lab%20Immunol&volume=6&pages=236-242&publication_year=1999&author=Gan%2CJ&author=Kendra%2CK&author=Ricci%2CM&author=Hank%2CJA&author=Gillies%2CSD&author=Sondel%2CPM?
- Find out how much https://doi.org/10.1084%2Fjem.155.6.1823 earns monthly
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6176669?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=The%20lymphokine-activated%20killer%20cell%20phenomenon.%20Lysis%20of%20natural%20killer-resistant%20fresh%20solid%20tumor%20cells%20by%20interleukin%202-activated%20autologous%20human%20peripheral%20blood%20lymphocytes&journal=J%20Exp%20Med&doi=10.1084%2Fjem.155.6.1823&volume=155&pages=1823-1841&publication_year=1982&author=Grimm%2CEA&author=Mazumder%2CA&author=Zhang%2CHZ&author=Rosenberg%2CSA produce monthly?
- What's the profit of https://doi.org/10.1097%2F00002371-199311000-00013?
- What's the revenue for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8280716?
- How much does http://scholar.google.com/scholar_lookup?&title=Activation%20of%20multiple%20effector%20mechanisms%20to%20enhance%20tumor%20immunotherapy&journal=J%20immunother&doi=10.1097%2F00002371-199311000-00013&volume=14&pages=329-335&publication_year=1993&author=Hank%2CJA&author=Albertini%2CMR&author=Schiller%2CJ&author=Sondel%2CPM make?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2386933
- How much does http://scholar.google.com/scholar_lookup?&title=Augmentation%20of%20antibody%20dependent%20cell%20mediated%20cytotoxicity%20following%20in%20vivo%20therapy%20with%20recombinant%20interleukin%202&journal=Cancer%20Res&volume=50&pages=5234-5239&publication_year=1990&author=Hank%2CJA&author=Robinson%2CRR&author=Surfus%2CJ&author=Mueller%2CBM&author=Reisfeld%2CRA&author=Cheung%2CNK&author=Sondel%2CPM generate monthly?
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10037176?
- http://scholar.google.com/scholar_lookup?&title=Distinct%20clinical%20and%20laboratory%20activity%20of%20two%20recombinant%20interleukin-2%20preparations&journal=Clin%20Cancer%20Res&volume=5&pages=281-289&publication_year=1999&author=Hank%2CJA&author=Surfus%2CJ&author=Gan%2CJ&author=Albertini%2CMR&author=Lindstrom%2CM&author=Schiller%2CJH&author=Hotton%2CKM&author=Khorsand%2CM&author=Sondel%2CPM's revenue stream
- How much does https://doi.org/10.1002%2F%28SICI%291097-0142%2820000415%2988%3A8%3C1892%3A%3AAID-CNCR19%3E3.0.CO%3B2-2 generate monthly?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10760767's financial summary
- http://scholar.google.com/scholar_lookup?&title=A%20phase%20Ib%2FII%20trial%20of%20granulocyte-macrophage-colony%20stimulating%20factor%20and%20interleukin-2%20for%20renal%20cell%20carcinoma%20patients%20with%20pulmonary%20metastases%3A%20a%20case%20of%20fatal%20central%20nervous%20system%20thrombosis&journal=Cancer&doi=10.1002%2F%28SICI%291097-0142%2820000415%2988%3A8%3C1892%3A%3AAID-CNCR19%3E3.0.CO%3B2-2&volume=88&pages=1892-1901&publication_year=2000&author=Hotton%2CKM&author=Khorsand%2CM&author=Hank%2CJA&author=Albertini%2CM&author=Kim%2CKM&author=Wilding%2CG&author=Salamat%2CMS&author=Larson%2CM&author=Sondel%2CP&author=Schiller%2CJH's financial summary
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10478638's gross income?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Pharmacokinetics%20and%20stability%20of%20the%20ch14.18-IL-2%20fusion%20protein%20in%20mice&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs002620050569&volume=48&pages=219-229&publication_year=1999&author=Kendra%2CK&author=Gan%2CJ&author=Ricci%2CM&author=Surfus%2CJ&author=Shaker%2CA&author=Super%2CM&author=Frost%2CJD&author=Rakhmilevich%2CA&author=Hank%2CJA&author=Gillies%2CSD&author=Sondel%2CPM?
- How much does https://doi.org/10.1097%2F00002371-199401000-00006 rake in every month?
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8110730?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Human%20immune%20response%20to%20monoclonal%20antibodies&journal=J%20Immunother&doi=10.1097%2F00002371-199401000-00006&volume=15&pages=42-52&publication_year=1994&author=Khazaeli%2CMB&author=Conry%2CRM&author=LoBuglio%2CAF bring in?
- How much revenue does https://doi.org/10.1200%2FJCO.2004.11.035 bring in?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15483010 bring in each month?
- How much money does http://scholar.google.com/scholar_lookup?&title=A%20phase%20I%20clinical%20trial%20of%20the%20immunocytokine%20EMD%20273063%20%28hu14.18-IL2%29%20in%20melanoma%20patients&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2004.11.035&volume=22&pages=4463-4473&publication_year=2004&author=King%2CDM&author=Albertini%2CMR&author=Schalch%2CH&author=Hank%2CJA&author=Gan%2CJ&author=Surfus%2CJ&author=Mahvi%2CD&author=Schiller%2CJH&author=Warner%2CT&author=Kim%2CK&author=Eickhoff%2CJ&author=Kendra%2CK&author=Reisfeld%2CR&author=Gillies%2CSD&author=Sondel%2CP generate?
- How much profit does https://doi.org/10.1002%2F1097-0142%2820000615%2988%3A12%3C2693%3A%3AAID-CNCR7%3E3.0.CO%3B2-3 make?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10870051?
- How much money does http://scholar.google.com/scholar_lookup?&title=Analysis%20of%20therapeutic%20and%20immunologic%20effects%20of%20R24%20anti-GD3%20monoclonal%20antibody%20in%2037%20patients%20with%20metastatic%20melanoma&journal=Cancer&doi=10.1002%2F1097-0142%2820000615%2988%3A12%3C2693%3A%3AAID-CNCR7%3E3.0.CO%3B2-3&volume=88&pages=2693-2702&publication_year=2000&author=Kirkwood%2CJM&author=Mascari%2CRA&author=Edington%2CHD&author=Rabkin%2CMS&author=Day%2CRS&author=Whiteside%2CTL&author=Vlock%2CDR&author=Shipe-Spotloe%2CJM make?
- How much does http://scholar.google.com/scholar_lookup?&title=Natural%20killer%20cell-mediated%20eradication%20of%20neuroblastoma%20metastases%20to%20bone%20marrow%20by%20targeted%20interleukin-2%20therapy&journal=Blood&volume=92&pages=1706-1715&publication_year=1998&author=Lode%2CHN&author=Xiang%2CR&author=Dreier%2CT&author=Varki%2CNM&author=Gillies%2CSD&author=Reisfeld%2CRA generate monthly?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6975652's gross income?
- Get to know http://scholar.google.com/scholar_lookup?&title=Lysis%20of%20fresh%20and%20cultured%20autologous%20tumor%20by%20lymphocytes%20cultured%20in%20T%20cell%20growth%20factor&journal=Cancer%20Res&volume=41&pages=4420-4425&publication_year=1981&author=Lotze%2CMT&author=Grimm%2CEA&author=Mazumder%2CA&author=Strausser%2CJL&author=Rosenberg%2CSA's earnings
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=2303711 pull in monthly?
- What is the earnings of http://scholar.google.com/scholar_lookup?&title=Enhancement%20of%20antibody-dependent%20cytotoxicity%20with%20a%20chimeric%20anti-GD2%20antibody&journal=J%20Immunol&volume=144&pages=1382-1386&publication_year=1990&author=Mueller%2CBM&author=Romerdahl%2CCA&author=Gillies%2CSD&author=Reisfeld%2CRA?
- How much money does http://scholar.google.com/scholar_lookup?&title=Flow%20cytometry%E2%80%94a%20rapid%20tool%20to%20correlate%20functional%20activities%20of%20human%20peripheral%20blood%20lymphocytes%20with%20their%20corresponding%20phenotypes%20after%20in%20vitro%20stimulation&journal=BMC%20Immunol&doi=10.1186%2F1471-2172-3-9&volume=3&publication_year=2002&author=Nirmala%2CR&author=Narayanan%2CPR generate?
- https://doi.org/10.1016%2F0022-1759%2884%2990154-6 income
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=6200539 each month?
- How much money does http://scholar.google.com/scholar_lookup?&title=The%20standardization%20of%20NK%20cell%20assays%20for%20use%20in%20studies%20of%20biological%20response%20modifiers&journal=J%20Immunol%20Methods&doi=10.1016%2F0022-1759%2884%2990154-6&volume=68&pages=235-249&publication_year=1984&author=Pross%2CHF&author=Maroun%2CJA make?
- What's the monthly income of https://doi.org/10.1097%2F00002371-199903000-00005?
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10093038 making per month?
- How much does http://scholar.google.com/scholar_lookup?&title=Gene%20gun-mediated%20IL-12%20gene%20therapy%20induces%20antitumor%20effects%20in%20the%20absence%20of%20toxicity%3A%20a%20direct%20comparison%20with%20systemic%20IL-12%20protein%20therapy&journal=J%20Immunother&doi=10.1097%2F00002371-199903000-00005&volume=22&pages=135-144&publication_year=1999&author=Rakhmilevich%2CAL&author=Timmins%2CJG&author=Janssen%2CK&author=Pohlmann%2CEL&author=Sheehy%2CMJ&author=Yang%2CNS pull in?
- How much profit does https://doi.org/10.1084%2Fjem.161.5.1169 make?
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3886826
- http://scholar.google.com/scholar_lookup?&title=Regression%20of%20established%20pulmonary%20metastases%20and%20subcutaneous%20tumor%20mediated%20by%20the%20systemic%20administration%20of%20high-dose%20recombinant%20interleukin%202&journal=J%20Exp%20Med&doi=10.1084%2Fjem.161.5.1169&volume=161&pages=1169-1188&publication_year=1985&author=Rosenberg%2CSA&author=Mule%2CJJ&author=Speiss%2CPJ&author=Reichert%2CCM&author=Schwarz%2CSL's financial summary
- How much money does https://doi.org/10.1001%2Fjama.271.12.907 make?
- How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8120958 generate?
- How much does http://scholar.google.com/scholar_lookup?&title=Treatment%20of%20283%20consecutive%20patients%20with%20metastatic%20melanoma%20or%20renal%20cell%20cancer%20using%20high-dose%20bolus%20interleukin%202&journal=JAMA&doi=10.1001%2Fjama.271.12.907&volume=271&pages=907-913&publication_year=1994&author=Rosenberg%2CSA&author=Yang%2CJC&author=Topalian%2CSL&author=Schwartzentruber%2CDJ&author=Weber%2CJS&author=Parkinson%2CDR&author=Seipp%2CCA&author=Einhorn%2CJH&author=White%2CDE generate monthly?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Phase%20I%20trial%20of%20the%20chimeric%20anti-GD2%20monoclonal%20antibody%20ch14.18%20in%20patients%20with%20malignant%20melanoma&journal=Hum%20Antib%20Hybrid&volume=3&pages=19-24&publication_year=1992&author=Saleh%2CMN&author=Khazaeli%2CMB&author=Wheeler%2CRH&author=Allen%2CL&author=Tilden%2CAB&author=Grizzle%2CW&author=Reisfeld%2CRA&author=Yu%2CAL&author=Gilles%2CSD&author=LoBuglio%2CAF?
- How much profit is https://doi.org/10.1038%2Fsj.cgt.7700012 making per month?
- See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10078967 makes per month
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=GM-CSF%20secreted%20by%20cDNA-transfected%20tumor%20cells%20induces%20a%20more%20potent%20antitumor%20response%20than%20exogenous%20GM-CSF&journal=Cancer%20Gene%20Ther&doi=10.1038%2Fsj.cgt.7700012&volume=6&pages=81-88&publication_year=1999&author=Shi%2CFS&author=Weber%2CS&author=Gan%2CJ&author=Rakhmilevich%2CAL&author=Mahvi%2CDM?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9815532 gross monthly?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Administration%20of%20R24%20monoclonal%20antibody%20and%20low-dose%20interleukin%202%20for%20malignant%20melanoma&journal=Clin%20Cancer%20Res&volume=3&pages=17-24&publication_year=1997&author=Soiffer%2CRJ&author=Chapman%2CPB&author=Murray%2CC&author=Williams%2CL&author=Unger%2CP&author=Collins%2CH&author=Houghton%2CAN&author=Ritz%2CJ
- What are the total earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=12901228?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Preclinical%20and%20clinical%20development%20of%20immunocytokines&journal=Curr%20Opin%20Investig%20Drugs&volume=4&pages=696-700&publication_year=2003&author=Sondel%2CPM&author=Hank%2CJA&author=Gan%2CJ&author=Neal%2CZ&author=Albertini%2CMR?
- How much does https://doi.org/10.1093%2Fjnci%2F80.18.1451 gross monthly?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=3263508's financial summary
- What's the revenue for http://scholar.google.com/scholar_lookup?&title=Repetitive%20weekly%20cycles%20of%20IL-2.%20II.%20Clinical%20and%20immunologic%20effects%20of%20dose%2C%20schedule%2C%20and%20addition%20of%20indomethacin&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2F80.18.1451&volume=80&pages=1451-1460&publication_year=1988&author=Sosman%2CJA&author=Kohler%2CPC&author=Hank%2CJA&author=Moore%2CKH&author=Bechhofer%2CR&author=Storer%2CB&author=Sondel%2CPM?
- Get to know http://scholar.google.com/scholar_lookup?&title=Phase%20I%20trial%20of%20a%20mouse%20monoclonal%20antibody%20against%20GD3%20ganglioside%20in%20patients%20with%20melanoma%3A%20induction%20of%20inflammatory%20responses%20at%20tumor%20sites&journal=J%20Clin%20Oncol&volume=6&pages=1639-1648&publication_year=1988&author=Vadhan-Raj%2CS&author=Cordon-Cardo%2CC&author=Carswell%2CE&author=Mintzer%2CD&author=Dantis%2CL&author=Duteau%2CC&author=Templeton%2CMA&author=Oettgen%2CHF&author=Old%2CLJ&author=Houghton%2CAN's earnings
- How profitable is https://doi.org/10.1002%2F%28SICI%291097-0215%2819970926%2973%3A1%3C42%3A%3AAID-IJC8%3E3.0.CO%3B2-1?
- How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9334808 have?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Selection%20of%20tumor%20antigens%20as%20targets%20for%20immune%20attack%20using%20immunohistochemistry%3A%20I.%20Focus%20on%20gangliosides&journal=Int%20J%20Cancer&doi=10.1002%2F%28SICI%291097-0215%2819970926%2973%3A1%3C42%3A%3AAID-IJC8%3E3.0.CO%3B2-1&volume=73&pages=42-49&publication_year=1997&author=Zhang%2CS&author=Cordon-Cardo%2CC&author=Zhang%2CHS&author=Reuter%2CVE&author=Adluri%2CS&author=Hamilton%2CWB&author=Lloyd%2CKO&author=Livingston%2CPO
- How much money does https://citation-needed.springer.com/v2/references/10.1007/s00262-005-0069-7?format=refman&flavour=references generate?
- Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Brian%20S.%20Choi
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Brian%20S.%20Choi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's total income per month
- Learn how profitable https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Paul%20M.%20Sondel is on a monthly basis
- Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Paul%20M.%20Sondel%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jacquelyn%20A.%20Hank bring in each month?
- Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jacquelyn%20A.%20Hank%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
- Get to know what's the income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Heidi%20Schalch
- How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Heidi%20Schalch%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jacek%20Gan?
- Earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jacek%20Gan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- Monthly income for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=David%20M.%20King
- What is the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22David%20M.%20King%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Learn how profitable https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kari%20Kendra is on a monthly basis
- How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kari%20Kendra%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=David%20Mahvi
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22David%20Mahvi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Li-Yin%20Lee each month?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Li-Yin%20Lee%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
- What's the monthly money flow for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=KyungMann%20Kim?
- Get to know https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22KyungMann%20Kim%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's earnings
- What's the monthly income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mark%20R.%20Albertini?
- How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mark%20R.%20Albertini%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
- How much profit does https://s100.copyright.com/AppDispatchServlet?title=Phase%20I%20trial%20of%20combined%20treatment%20with%20ch14.18%20and%20R24%20monoclonal%20antibodies%20and%20interleukin-2%20for%20patients%20with%20melanoma%20or%20sarcoma&author=Brian%20S.%20Choi%20et%20al&contentID=10.1007%2Fs00262-005-0069-7©right=Springer-Verlag&publication=0340-7004&publicationDate=2005-09-27&publisherName=SpringerNature&orderBeanReset=true make?
- How much does https://citation-needed.springer.com/v2/references/10.1007/s00262-005-0069-7?format=refman&flavour=citation rake in every month?
- How much does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral rake in every month?
- Learn how profitable https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research is on a monthly basis
- Check the income stats for https://www.springernature.com/gp/products
- How much money does https://www.springernature.com/gp/librarians make?
- Financial intake of https://www.springernature.com/gp/societies
- How much revenue does https://www.springernature.com/gp/partners bring in?
- How much profit does https://www.springer.com/ generate?
- How much money does https://www.nature.com/ generate?
- How much does https://www.biomedcentral.com/ gross monthly?
- How much does https://www.palgrave.com/ net monthly?
- https://www.apress.com/'s financial summary
- https://www.springernature.com/gp/legal/ccpa's financial summary
- Profit of https://www.springernature.com/gp/info/accessibility
- What is the monthly revenue of https://support.springernature.com/en/support/home?
- What's the financial gain of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
- Monthly income for https://www.springernature.com/
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Clipboard.js
- Prism.js
CDN Services {📦}
- Crossref